Protein kinase G type II is required for night-to-day progression of the mammalian circadian clock

Shelley A. Tischkau, Jennifer W. Mitchell, Laura A. Pace, Jessica W. Barnes, Jeffrey A. Barnes, Martha L Gillette

Research output: Contribution to journalArticle

Abstract

Circadian clocks comprise a cyclic series of dynamic cellular states, characterized by the changing availability of substrates that alter clock time when activated. To determine whether circadian clocks, like the cell cycle, exhibit regulation by key phosphorylation events, we examined endogenous kinase regulation of timekeeping in the mammalian suprachiasmatic nucleus (SCN). Short-term inhibition of PKG-II but not PKG-Iβ using antisense oligodeoxynucleotides delayed rhythms of electrical activity and Bmal1 mRNA. Phase resetting was rapid and dynamic; inhibition of PKG-II forced repetition of the last 3.5 hr of the cycle. Chronic inhibition of PKG-II disrupted electrical activity rhythms and tonically increased Bmal1 mRNA. PKG-II-like immunoreactivity was detected after coimmunoprecipitation with CLOCK, and CLOCK was phosphorylated in the presence of active PKG-II. PKG-II activation may define a critical control point for temporal progression into the daytime domain by acting on the positive arm of the transcriptional/translational feedback loop.

Original languageEnglish (US)
Pages (from-to)539-549
Number of pages11
JournalNeuron
Volume43
Issue number4
DOIs
StatePublished - Aug 19 2004

Fingerprint

Cyclic GMP-Dependent Protein Kinases
Circadian Clocks
Messenger RNA
Suprachiasmatic Nucleus
Oligodeoxyribonucleotides
Cell Cycle
Phosphotransferases
Phosphorylation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Protein kinase G type II is required for night-to-day progression of the mammalian circadian clock. / Tischkau, Shelley A.; Mitchell, Jennifer W.; Pace, Laura A.; Barnes, Jessica W.; Barnes, Jeffrey A.; Gillette, Martha L.

In: Neuron, Vol. 43, No. 4, 19.08.2004, p. 539-549.

Research output: Contribution to journalArticle

Tischkau, Shelley A. ; Mitchell, Jennifer W. ; Pace, Laura A. ; Barnes, Jessica W. ; Barnes, Jeffrey A. ; Gillette, Martha L. / Protein kinase G type II is required for night-to-day progression of the mammalian circadian clock. In: Neuron. 2004 ; Vol. 43, No. 4. pp. 539-549.
@article{74a1201df4654416aec64d396ebb8764,
title = "Protein kinase G type II is required for night-to-day progression of the mammalian circadian clock",
abstract = "Circadian clocks comprise a cyclic series of dynamic cellular states, characterized by the changing availability of substrates that alter clock time when activated. To determine whether circadian clocks, like the cell cycle, exhibit regulation by key phosphorylation events, we examined endogenous kinase regulation of timekeeping in the mammalian suprachiasmatic nucleus (SCN). Short-term inhibition of PKG-II but not PKG-Iβ using antisense oligodeoxynucleotides delayed rhythms of electrical activity and Bmal1 mRNA. Phase resetting was rapid and dynamic; inhibition of PKG-II forced repetition of the last 3.5 hr of the cycle. Chronic inhibition of PKG-II disrupted electrical activity rhythms and tonically increased Bmal1 mRNA. PKG-II-like immunoreactivity was detected after coimmunoprecipitation with CLOCK, and CLOCK was phosphorylated in the presence of active PKG-II. PKG-II activation may define a critical control point for temporal progression into the daytime domain by acting on the positive arm of the transcriptional/translational feedback loop.",
author = "Tischkau, {Shelley A.} and Mitchell, {Jennifer W.} and Pace, {Laura A.} and Barnes, {Jessica W.} and Barnes, {Jeffrey A.} and Gillette, {Martha L}",
year = "2004",
month = "8",
day = "19",
doi = "10.1016/j.neuron.2004.07.027",
language = "English (US)",
volume = "43",
pages = "539--549",
journal = "Neuron",
issn = "0896-6273",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Protein kinase G type II is required for night-to-day progression of the mammalian circadian clock

AU - Tischkau, Shelley A.

AU - Mitchell, Jennifer W.

AU - Pace, Laura A.

AU - Barnes, Jessica W.

AU - Barnes, Jeffrey A.

AU - Gillette, Martha L

PY - 2004/8/19

Y1 - 2004/8/19

N2 - Circadian clocks comprise a cyclic series of dynamic cellular states, characterized by the changing availability of substrates that alter clock time when activated. To determine whether circadian clocks, like the cell cycle, exhibit regulation by key phosphorylation events, we examined endogenous kinase regulation of timekeeping in the mammalian suprachiasmatic nucleus (SCN). Short-term inhibition of PKG-II but not PKG-Iβ using antisense oligodeoxynucleotides delayed rhythms of electrical activity and Bmal1 mRNA. Phase resetting was rapid and dynamic; inhibition of PKG-II forced repetition of the last 3.5 hr of the cycle. Chronic inhibition of PKG-II disrupted electrical activity rhythms and tonically increased Bmal1 mRNA. PKG-II-like immunoreactivity was detected after coimmunoprecipitation with CLOCK, and CLOCK was phosphorylated in the presence of active PKG-II. PKG-II activation may define a critical control point for temporal progression into the daytime domain by acting on the positive arm of the transcriptional/translational feedback loop.

AB - Circadian clocks comprise a cyclic series of dynamic cellular states, characterized by the changing availability of substrates that alter clock time when activated. To determine whether circadian clocks, like the cell cycle, exhibit regulation by key phosphorylation events, we examined endogenous kinase regulation of timekeeping in the mammalian suprachiasmatic nucleus (SCN). Short-term inhibition of PKG-II but not PKG-Iβ using antisense oligodeoxynucleotides delayed rhythms of electrical activity and Bmal1 mRNA. Phase resetting was rapid and dynamic; inhibition of PKG-II forced repetition of the last 3.5 hr of the cycle. Chronic inhibition of PKG-II disrupted electrical activity rhythms and tonically increased Bmal1 mRNA. PKG-II-like immunoreactivity was detected after coimmunoprecipitation with CLOCK, and CLOCK was phosphorylated in the presence of active PKG-II. PKG-II activation may define a critical control point for temporal progression into the daytime domain by acting on the positive arm of the transcriptional/translational feedback loop.

UR - http://www.scopus.com/inward/record.url?scp=4143147421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143147421&partnerID=8YFLogxK

U2 - 10.1016/j.neuron.2004.07.027

DO - 10.1016/j.neuron.2004.07.027

M3 - Article

C2 - 15312652

AN - SCOPUS:4143147421

VL - 43

SP - 539

EP - 549

JO - Neuron

JF - Neuron

SN - 0896-6273

IS - 4

ER -